Fidelity SPDR Advertisement
Home > Boards > Free Zone > All Trading - Technical > GoodFellas Big Board Catalyst and Chart Plays

GNOM - Research/DD summary & charts !

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
dDT  Member Profile
Member Level 
Followed By 477
Posts 68,838
Boards Moderated 3
Alias Born 03/31/08
160x600 placeholder
U.s. Gdp Expands At 3.5% Rate
U.S. GDP advanced at a seasonally adjusted annual rate of 3.5% in 3Q, a sign of sustained growth fueled by government spending and a narrower trade deficit despite mounting concerns about the health of overseas economies.
More Top Equities Stories Of The Day
European Markets Show Signs of Stress--2nd Update
ADR Shares End Mixed; Sanofi, Banco Bilbao Vizcaya Argentaria Shares Fall
Shire Files 8K - Other Events
Apple CEO Says He's 'Proud to Be Gay'
Stoxx 600 Flirts With Three-week High
U.S. Stocks, Bonds Dip on Fed Outlook
FTSE 100 Ends Higher After Roller-coaster Day
European Stocks Climb For Third Straight Day
dDT Member Level  Saturday, 01/07/12 08:05:22 AM
Re: dDT post# 1694
Post # of 81351 
GNOM - Research/DD summary & charts !

Complete Genomics, Inc., a life sciences company, develops and commercializes a DNA sequencing platform for human genome sequencing and analysis. Its Complete Genomics Analysis platform combines its proprietary human genome sequencing technology with informatics and data management software to provide customers with data that is ready to be used for genome-based research. The company's human genome sequencing services have applications in cancer research, Mendelian disease research, rare variant disease research, and clinical trial optimization. Its customers include academic and government research centers, and biopharmaceutical companies. The company was founded in 2005 and is headquartered in Mountain View, California.

Company's website: http://www.completegenomics.com/

Financial Reports: http://ir.completegenomics.com/financials.cfm

SEC filings: http://ir.completegenomics.com/sec.cfm

Nasdaq.com Stock Research - Analyst Summary

http://www.nasdaq.com/symbol/gnom/analyst-research


Contacts

Investor Relations Contact:
Scott Sandler
Director, Financial Planning & Analysis
Complete Genomics, Inc.
ssandler@completegenomics.com
650.943.2788

GNOM Chart


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist